Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 24 | 2023 | 5508 | 1.200 |
Why?
|
Skin Neoplasms | 13 | 2023 | 5691 | 0.600 |
Why?
|
Stromal Cells | 2 | 2016 | 1356 | 0.400 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.400 |
Why?
|
Antigens, Neoplasm | 3 | 2022 | 1988 | 0.310 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2022 | 303 | 0.300 |
Why?
|
Killer Cells, Natural | 3 | 2020 | 2131 | 0.270 |
Why?
|
Cancer Vaccines | 3 | 2021 | 1023 | 0.270 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1038 | 0.260 |
Why?
|
Cell Proliferation | 3 | 2020 | 10477 | 0.250 |
Why?
|
Cell Movement | 1 | 2016 | 5216 | 0.240 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4848 | 0.220 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2023 | 136 | 0.220 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2020 | 1366 | 0.210 |
Why?
|
Nevus, Blue | 1 | 2022 | 38 | 0.210 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5170 | 0.200 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1608 | 0.200 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3617 | 0.190 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3583 | 0.190 |
Why?
|
Activating Transcription Factor 3 | 1 | 2020 | 54 | 0.190 |
Why?
|
Tumor Cells, Cultured | 5 | 2022 | 6311 | 0.180 |
Why?
|
Uveal Neoplasms | 1 | 2022 | 310 | 0.180 |
Why?
|
RNA Stability | 1 | 2019 | 320 | 0.150 |
Why?
|
Antibodies, Blocking | 1 | 2018 | 253 | 0.150 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2177 | 0.150 |
Why?
|
Genomics | 3 | 2023 | 5714 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2540 | 0.140 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2017 | 175 | 0.140 |
Why?
|
Epitopes | 2 | 2021 | 2570 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2022 | 803 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2022 | 9239 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 323 | 0.140 |
Why?
|
MutS Homolog 2 Protein | 1 | 2016 | 200 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 350 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 539 | 0.130 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 537 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1821 | 0.130 |
Why?
|
Immunologic Memory | 1 | 2021 | 1347 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8430 | 0.110 |
Why?
|
Nevus, Pigmented | 1 | 2015 | 219 | 0.110 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2014 | 195 | 0.110 |
Why?
|
Lymph Node Excision | 1 | 2019 | 1262 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 2039 | 0.110 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6363 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1434 | 0.110 |
Why?
|
Conserved Sequence | 1 | 2016 | 1202 | 0.110 |
Why?
|
Coculture Techniques | 1 | 2016 | 1342 | 0.110 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11036 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4386 | 0.100 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 16674 | 0.100 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9272 | 0.100 |
Why?
|
Pancreatectomy | 1 | 2016 | 804 | 0.100 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 604 | 0.100 |
Why?
|
Cell Nucleus | 1 | 2020 | 2969 | 0.100 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1783 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.100 |
Why?
|
Mice, Nude | 3 | 2020 | 3680 | 0.090 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2020 | 91 | 0.080 |
Why?
|
Indoles | 1 | 2017 | 1841 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1691 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2017 | 3205 | 0.080 |
Why?
|
Mice | 12 | 2023 | 81154 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.080 |
Why?
|
Mutation | 5 | 2022 | 29777 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5532 | 0.080 |
Why?
|
ras Proteins | 2 | 2018 | 1059 | 0.080 |
Why?
|
Genetic Loci | 1 | 2017 | 2575 | 0.080 |
Why?
|
Sulfonamides | 1 | 2017 | 1938 | 0.080 |
Why?
|
Monocytes | 1 | 2017 | 2593 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3476 | 0.080 |
Why?
|
Humans | 37 | 2023 | 743811 | 0.070 |
Why?
|
SOS1 Protein | 1 | 2007 | 41 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10179 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2014 | 851 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1295 | 0.070 |
Why?
|
Melanoma, Experimental | 2 | 2020 | 560 | 0.070 |
Why?
|
Signal Transduction | 5 | 2019 | 23398 | 0.070 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2009 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2942 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13691 | 0.060 |
Why?
|
Animals | 14 | 2023 | 168660 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4418 | 0.060 |
Why?
|
Ligands | 2 | 2023 | 3281 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2492 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2013 | 1332 | 0.060 |
Why?
|
Palatine Tonsil | 1 | 2023 | 193 | 0.060 |
Why?
|
Response Elements | 1 | 2023 | 312 | 0.050 |
Why?
|
MAP Kinase Signaling System | 2 | 2020 | 1524 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2022 | 100 | 0.050 |
Why?
|
Base Sequence | 3 | 2019 | 12798 | 0.050 |
Why?
|
Oncogene Protein v-akt | 1 | 2020 | 135 | 0.050 |
Why?
|
Chemokines, C | 1 | 2019 | 9 | 0.050 |
Why?
|
RNA | 2 | 2023 | 2748 | 0.050 |
Why?
|
Tristetraprolin | 1 | 2019 | 42 | 0.040 |
Why?
|
Apoptosis | 3 | 2020 | 9718 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 303 | 0.040 |
Why?
|
Cross-Priming | 1 | 2019 | 82 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2019 | 1284 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13869 | 0.040 |
Why?
|
SEER Program | 2 | 2015 | 1507 | 0.040 |
Why?
|
Organ Specificity | 1 | 2023 | 2008 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2023 | 1081 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 290 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 972 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 5264 | 0.040 |
Why?
|
Cell Culture Techniques | 2 | 2017 | 1677 | 0.040 |
Why?
|
Immunocompetence | 1 | 2018 | 136 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2007 | 1417 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12786 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2022 | 715 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3482 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2938 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1602 | 0.040 |
Why?
|
Male | 13 | 2022 | 349776 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2017 | 196 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2017 | 382 | 0.040 |
Why?
|
Axilla | 1 | 2019 | 597 | 0.040 |
Why?
|
Transcription Factor Brn-3A | 1 | 2016 | 12 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7880 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 21824 | 0.040 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1723 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2022 | 11478 | 0.040 |
Why?
|
HLA Antigens | 1 | 2022 | 1382 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.030 |
Why?
|
Female | 13 | 2022 | 380020 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4477 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9440 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 841 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 348 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2006 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13112 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1876 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6773 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 968 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1770 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.030 |
Why?
|
Placebos | 1 | 2019 | 1674 | 0.030 |
Why?
|
Phenotype | 3 | 2022 | 16361 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 8856 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14563 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2015 | 139 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 196 | 0.030 |
Why?
|
Aged | 8 | 2020 | 163178 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1676 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2018 | 581 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2718 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2022 | 77410 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2029 | 0.030 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2016 | 252 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3591 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2020 | 1423 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3130 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15281 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 637 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1880 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1475 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2015 | 449 | 0.030 |
Why?
|
Middle Aged | 8 | 2019 | 213241 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3510 | 0.030 |
Why?
|
Leg | 1 | 2017 | 1116 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2019 | 57744 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 890 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1083 | 0.030 |
Why?
|
Melanocytes | 1 | 2015 | 515 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3547 | 0.030 |
Why?
|
Chromatin | 1 | 2023 | 2931 | 0.030 |
Why?
|
Immunotherapy | 2 | 2018 | 4437 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2019 | 2924 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3480 | 0.020 |
Why?
|
Hippocampus | 1 | 2023 | 3672 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39001 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21675 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2017 | 13809 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 828 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3645 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2014 | 598 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1055 | 0.020 |
Why?
|
Adult | 6 | 2020 | 213889 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8436 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2504 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2110 | 0.020 |
Why?
|
Cell Communication | 1 | 2016 | 1621 | 0.020 |
Why?
|
Child | 3 | 2022 | 77637 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12020 | 0.020 |
Why?
|
Gastrectomy | 1 | 2013 | 663 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3515 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1962 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2019 | 2961 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2963 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5973 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1917 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4204 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4221 | 0.020 |
Why?
|
raf Kinases | 1 | 2007 | 122 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3337 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2720 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 56392 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2850 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5524 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 29052 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3504 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2019 | 13028 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6750 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2007 | 709 | 0.010 |
Why?
|
Adolescent | 3 | 2019 | 85729 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11360 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12209 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9377 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10251 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8660 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9944 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7324 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2256 | 0.010 |
Why?
|
Palliative Care | 1 | 2017 | 3490 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7784 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7719 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11524 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18027 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3701 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8637 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3847 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9582 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12354 | 0.010 |
Why?
|
RNA Interference | 1 | 2007 | 2890 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 20948 | 0.010 |
Why?
|
Brain | 1 | 2023 | 26345 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5445 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18355 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40038 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 63042 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 18107 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17439 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 23327 | 0.010 |
Why?
|